US 9789096
Methods and compositions for selective and targeted cancer therapy
granted A61KA61K31/381A61K31/426
Quick answer
US patent 9789096 (Methods and compositions for selective and targeted cancer therapy) held by The Board of Regents of the University of Texas System expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/381, A61K31/426, A61K31/428, A61P